Verily Acquires SignalPath

August 17, 2021

Verily, an Alphabet company, has acquired SignalPath, a Raleigh-based clinical trial management system (CTMS) provider and portfolio company of Highlander Partners. The deal brings SignalPath's site-focused CTMS and network of research sites into Verily's Baseline clinical studies platform to accelerate clinical trial execution, decentralization and evidence generation; SignalPath employees will join Verily and remain based in Raleigh.

Buyers
Verily
Targets
SignalPath
Sellers
Highlander Partners
Industry
Cloud & SaaS
Location
North Carolina, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.